Amplification of the transcription factor MYCN, which along with high c-Myc expression is frequently observed in high-risk neuroblastoma, leads to an increased oncogenic transcriptional programme29 whereby cells may rely more heavily on rapid and correct pre-mRNA processing and alternative splicing30. Here, MYCN is linked to neuroblastoma.